FDA Approved: TYRVAYA — Original Application (Oyster Point Pharma, Inc.)

View source ↗

Summary

FDA approved TYRVAYA (varenicline nasal spray) through an Original NDA from Oyster Point Pharma, establishing a nasal spray formulation for smoking cessation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Tyrvaya (varenicline)

Snippet

ORIG AP for TYRVAYA (VARENICLINE)